Annuncio pubblicitario
Italia markets open in 40 minutes

  • Dow Jones

    37.903,29
    +87,37 (+0,23%)
     

  • Nasdaq

    15.605,48
    -52,34 (-0,33%)
     

  • Nikkei 225

    38.236,07
    -37,98 (-0,10%)
     

  • EUR/USD

    1,0727
    +0,0009 (+0,09%)
     

  • Bitcoin EUR

    53.664,38
    -2.169,00 (-3,88%)
     

  • CMC Crypto 200

    1.259,57
    -11,18 (-0,88%)
     

  • HANG SENG

    18.186,95
    +423,92 (+2,39%)
     

  • S&P 500

    5.018,39
    -17,30 (-0,34%)
     

G1 Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

G1 Therapeutics
·1 minuto per la lettura
G1 Therapeutics
G1 Therapeutics

RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Communications Officer Will Roberts will provide a corporate presentation on September 12, 2023, at 9:30 AM EDT during the H.C. Wainwright 25th Annual Global Investment Conference.

The webcast of the event will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.

About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA® (trilaciclib). G1 has a deep clinical pipeline and is executing a development plan evaluating trilaciclib in a variety of solid tumors, including breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

ANNUNCIO PUBBLICITARIO

G1 Therapeutics® and the G1 Therapeutics logo and COSELA® and the COSELA logo are trademarks of G1 Therapeutics, Inc

Contacts:
Will Roberts
Communications Officer
Vice President, Investor Relations & Corporate Communications
919-907-1944
wroberts@g1therapeutics.com